INS and diabetes mellitus: PMI5011 is a well-characterized botanical extract from A. dracunculus L., whose effects on carbohydrate metabolism are comparable to the ability of known antidiabetic drugs (troglitazone and metformin) to lower glucose and insulin levels in murine models of diabetes and insulin resistance [16].